Cargando…
Challenges in the Pharmacologic Management of Obesity and Secondary Dyslipidemia in Children and Adolescents
The rise in childhood obesity has lead to an increased number of children with lipid abnormalities and the predominance of a combined dyslipidemic pattern characterized by a moderate-to-severe elevation in triglycerides, normal-to-mild mild elevation in LDL cholesterol and reduced HDL cholesterol. A...
Autores principales: | Kennedy, Mary Jayne, Jellerson, Kevin D., Snow, Michael Z., Zacchetti, Michelle L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781297/ https://www.ncbi.nlm.nih.gov/pubmed/23677836 http://dx.doi.org/10.1007/s40272-013-0028-2 |
Ejemplares similares
-
The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA
por: Baum, Charles, et al.
Publicado: (2015) -
Secondary Dyslipidemia In Obese Children - Is There Evidence For
Pharmacological Treatment?
por: Tanaka, Ana Cristina Sayuri
Publicado: (2018) -
Secondary Dyslipidemia In Obese Children - Is There Evidence For
Pharmacological Treatment?
por: Radaelli, Graciane, et al.
Publicado: (2018) -
Sea otter health: Challenging a pet hypothesis
por: Lafferty, Kevin D.
Publicado: (2015) -
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities
por: Pascual, Juan C., et al.
Publicado: (2023)